125 related articles for article (PubMed ID: 30542533)
1. Novel tricyclic glycal-based
Nagiec MM; Duvall JR; Skepner AP; Howe EA; Bastien J; Comer E; Marie JC; Johnston SE; Negri J; Eichhorn M; Vantourout J; Clish C; Musunuru K; Foley M; Perez JR; Palmer MAJ
Medchemcomm; 2018 Nov; 9(11):1831-1842. PubMed ID: 30542533
[TBL] [Abstract][Full Text] [Related]
2. Modulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expression.
Nagiec MM; Skepner AP; Negri J; Eichhorn M; Kuperwasser N; Comer E; Muncipinto G; Subramanian A; Clish C; Musunuru K; Duvall JR; Foley M; Perez JR; Palmer MA
PLoS One; 2015; 10(3):e0120295. PubMed ID: 25811180
[TBL] [Abstract][Full Text] [Related]
3. Role of Tribbles Pseudokinase 1 (TRIB1) in human hepatocyte metabolism.
Soubeyrand S; Martinuk A; Naing T; Lau P; McPherson R
Biochim Biophys Acta; 2016 Feb; 1862(2):223-32. PubMed ID: 26657055
[TBL] [Abstract][Full Text] [Related]
4. The role of TRIB1 in lipid metabolism; from genetics to pathways.
Iwamoto S; Boonvisut S; Makishima S; Ishizuka Y; Watanabe K; Nakayama K
Biochem Soc Trans; 2015 Oct; 43(5):1063-8. PubMed ID: 26517924
[TBL] [Abstract][Full Text] [Related]
5. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
[TBL] [Abstract][Full Text] [Related]
6. TRIB1 downregulates hepatic lipogenesis and glycogenesis via multiple molecular interactions.
Ishizuka Y; Nakayama K; Ogawa A; Makishima S; Boonvisut S; Hirao A; Iwasaki Y; Yada T; Yanagisawa Y; Miyashita H; Takahashi M; Iwamoto S;
J Mol Endocrinol; 2014 Apr; 52(2):145-58. PubMed ID: 24389359
[TBL] [Abstract][Full Text] [Related]
7. ERK1/2 regulates hepatocyte Trib1 in response to mitochondrial dysfunction.
Soubeyrand S; Naing T; Martinuk A; McPherson R
Biochim Biophys Acta; 2013 Dec; 1833(12):3405-3414. PubMed ID: 24161842
[TBL] [Abstract][Full Text] [Related]
8. Tribbles-1 regulates hepatic lipogenesis through posttranscriptional regulation of C/EBPα.
Bauer RC; Sasaki M; Cohen DM; Cui J; Smith MA; Yenilmez BO; Steger DJ; Rader DJ
J Clin Invest; 2015 Oct; 125(10):3809-18. PubMed ID: 26348894
[TBL] [Abstract][Full Text] [Related]
9. Trouble With Tribbles-1.
Jadhav KS; Bauer RC
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):998-1005. PubMed ID: 31018662
[TBL] [Abstract][Full Text] [Related]
10. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
11. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
Kwiterovich PO
Am J Cardiol; 2002 Oct; 90(8A):30i-47i. PubMed ID: 12419479
[TBL] [Abstract][Full Text] [Related]
13. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
14. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
15. Statins for treatment of dyslipidemia in chronic kidney disease.
Shurraw S; Tonelli M
Perit Dial Int; 2006; 26(5):523-39. PubMed ID: 16973506
[TBL] [Abstract][Full Text] [Related]
16. Tribbles-1: a novel regulator of hepatic lipid metabolism in humans.
Bauer RC; Yenilmez BO; Rader DJ
Biochem Soc Trans; 2015 Oct; 43(5):1079-84. PubMed ID: 26517927
[TBL] [Abstract][Full Text] [Related]
17. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
Dashti N; Alaupovic P; Knight-Gibson C; Koren E
Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101
[TBL] [Abstract][Full Text] [Related]
18. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of low density lipoprotein receptor activity by tumor necrosis factor, a process independent of tumor necrosis factor-induced lipid synthesis and secretion.
Liao W; Florén CH
Lipids; 1994 Oct; 29(10):679-84. PubMed ID: 7861934
[TBL] [Abstract][Full Text] [Related]
20. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction.
Tornvall P; Karpe F; Carlson LA; Hamsten A
Atherosclerosis; 1991 Sep; 90(1):67-80. PubMed ID: 1799399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
